AIR-DS

Detect early-stage cancer with a cheek swab.

A 10-second cheek swab and basic medical history can detect signs of lung cancer, even at stage I. Sierra's technology is 97% accurate in finding cancer (sensitivity) and 91% accurate in ruling it out (specificity).

Book a demo with Josh

(friendly tour, not a sales pitch)

〉

Supported by:

AIR-DS changes how we'll treat cancer

Early Detection Saves Lives
Early Detection Saves Lives:
Identify cancer risk at its earliest, most treatable stage. Currently, only 30% of cancers are detected before stage III. AIR-DS is equally accurate for stage I or stage IV cases.
Zhang, Y., Simoff, M.J., Ost, D. et al. Understanding the patient journey to diagnosis of lung cancer. BMC Cancer 21, 402 (2021). https://doi.org/10.1186/s12885-021-08067-1
Non-Invasive Sampling
Non-Invasive Sampling:
No needles, no discomfort, no genetics — just a simple cheek swab for convenient testing. Simple decision and consent for patients.
Care Pathway Evolved
Care Pathway Evolved:
A minor modification to existing care pathways to reduce pressure on radiology departments, not a revolution. Proven net monetary benefit for existing systems.

The Process

1.

You Request

Take a buccal cell swab and send to Sierra's lab using your existing logistics supplier.

2.

We Process

Our laboratory partners will generate the IR spectra and we'll run signal processing, quality control, inference and explainability on the data.

Interested in becoming a lab partner?
3.

You Receive

Within 24 hours of receipt, you'll receive a decision support report which gives you all the information needed to determine high suspicion of cancer. Onwards referral at your discretion.

© 2024 Sierra Medical Ltd.

info@sierramedical.co.uk

Ketton Suite, The King Centre, Main Road, Barleythorpe, Rutland, LE15 7WD